Private Advisor Group, LLC Esperion Therapeutics, Inc. Transaction History
Private Advisor Group, LLC
- $15.8 Billion
- Q1 2025
A detailed history of Private Advisor Group, LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Private Advisor Group, LLC holds 40,106 shares of ESPR stock, worth $44,918. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,106
Previous 30,106
33.22%
Holding current value
$44,918
Previous $66,000
13.64%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding ESPR
# of Institutions
200Shares Held
119MCall Options Held
171KPut Options Held
679K-
Black Rock Inc. New York, NY14MShares$15.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.5MShares$12.9 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.9MShares$12.2 Million0.09% of portfolio
-
Bellevue Group Ag Kuesnacht, V89.69MShares$10.9 Million0.32% of portfolio
-
Two Seas Capital LP Rye, NY6.93MShares$7.76 Million0.36% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $74.5M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...